BPC-157

You may benefit from

BPC-157

BPC-157

15 amino acids derived from human gastric juice.

  • lowers inflammation
  • strengthens the gut barrier
  • improves blood flow
  • enhances healing
  • increases dopamine production

BPC-157: Interactive 3D model

15 amino acids14 peptide bonds198 atoms

Drag to move · scroll to zoom · 360 to rotate

A computer model of one possible shape of BPC-157, all 198 atoms, drawn uncharged. Built from the sequence GEPPPGKPADDAGLV with RDKit and energy-minimised (MMFF). In water the chain keeps moving, so no single shape is "the" shape. Colours mark the amino acids; the white links are the 14 peptide bonds between them.

Blood flow and blood vessels

01Rats + human cells

BPC-157 activates VEGF and promotes new blood vessel formation

Hsieh et al. · J Mol Med, 2017 · rats with a blocked leg artery, plus human vessel cells in a dish

Title of the study: Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

Treated rats got blood flow back faster and grew more vessels in the ischemic leg. In human vessel cells, BPC-157 raised VEGFR2 receptors and switched on the Akt and eNOS signal that starts capillary growth. [1]

This paper is not open access, so only its title is shown here.

Read it on PubMed

Knee pain, in people

02People · 16 patients

Relieves knee pain

Lee & Padgett · Altern Ther Health Med, 2021 · Institute for Hormonal Balance, Orlando, Florida · chart review of 17 patients treated in 2019 and 2020, 16 reached by phone

Title of the study: Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain

A clinic injected BPC-157 straight into the knee of patients with knee pain from different causes: 12 got BPC-157 alone and 4 got it together with thymosin beta-4 (TB-4). Six months to a year later the clinic called them and asked one question, did the pain improve. 11 of the 12 on BPC-157 alone said it improved significantly, as did 3 of the 4 on the combination: 14 of 16 overall. It is the only study of BPC-157 injected into a joint in people, but it is a look back at one clinic's records: no control group, no pain scale or scan, only what patients remembered months later. [2]

Bar chart: 87.5% of patients (14 of 16) reported significant knee pain improvement, 12.5% (2 of 16) did not
Share of all 16 patients who reported a significant improvement, and who did not. Chart drawn by OxidativeState from the numbers in the abstract.
Read it on PubMed

Blood vessels, in human tissue

03Human artery tissue

Promotes vasodilation

Yildirim et al. · J Clin Med, 2026 · Ankara, Turkey · artery segments left over from bypass surgery in 12 patients

Title of the study: Vasorelaxant effects of BPC 157 in human internal mammary artery

Rings of the internal mammary artery, 11 with the lining intact and 11 without, relaxed as the dose went up. The effect was stronger with the lining intact and smaller with a nitric oxide blocker. Human tissue, but not a trial in people. The authors call it early mechanistic evidence. [3]

Dose-response curves of human artery rings relaxing with BPC-157
Contraction left in human artery rings as the BPC-157 dose rises; lower means more relaxed. Green: lining intact. Blue: lining removed. 11 rings each. Figure 1 from Yildirim et al., J Clin Med 2026, CC BY.
Read it on PubMed

Tendons, muscle and the gut

043 studies

Heals gastric tissue

Rats · 6 per group

Japjec et al. · Biomedicines, 2021 · Zagreb · rats with the quadriceps tendon cut from its muscle, 6 per group and time point

Title of the study: BPC 157 as a therapy for the disabled myotendinous junctions in rats

This injury does not heal on its own in rats. With BPC-157 by injection or in drinking water, the rats regained full function and the muscle wasting seen in every control was stopped, up to day 42. [4]

Rat legs at day 28: a wasted muscle in the control and a near-normal one with BPC-157
Day 28: the control leg shows muscle wasting, the treated leg looks close to normal. Figure 8 from Japjec et al., Biomedicines 2021, CC BY.
Read it on PubMed

Rats · 6 per group · by mouth

Matek et al. · Pharmaceutics, 2025 · Zagreb · rats with the quadriceps cut off the bone, 6 per group and time point

Title of the study: BPC 157 as therapy after surgical detachment of the quadriceps muscle

Untreated, the knee stayed bent and walking stayed impaired. With BPC-157 by mouth, the muscle reattached to new bone, walking fully normalized and the contracture disappeared. The effect held at every check up to 90 days. [5]

Thigh muscle diameter at 3 months, control against BPC-157
Thigh muscle at 3 months. The red arrow marks the thin muscle in the control, the blue arrow the thicker muscle with BPC-157. Figure 6 from Matek et al., Pharmaceutics 2025, CC BY.
Read it on PubMed

Rats

Skorjanec et al. · Dig Dis Sci, 2009 · rats with a channel between the stomach and the skin

Title of the study: Therapy for unhealed gastrocutaneous fistulas in rats

BPC-157 in drinking water or by injection healed both the skin wound and the stomach defect and closed the fistulas, even in rats given a corticosteroid that slows healing. It did better than atropine, ranitidine and omeprazole, the standard ulcer drugs. [6]

This paper is not open access, so only its title is shown here.

Read it on PubMed

Nerves and brain

05Rats · at least 6 per group

Enhances recovery from a spinal cord injury

Perovic et al. · J Orthop Surg Res, 2019 · Zagreb · rats with a compressed spinal cord, at least 6 per group and time point

Title of the study: BPC 157 can improve the healing course of spinal cord injury in rats

One injection, 10 minutes after the injury. Treated rats got their tail movement back and their spasticity was gone by day 15. In the controls it lasted until the end of the study, day 360. The loss of nerve cells and axons was counteracted. [7]

Tail function scores over time, control against BPC-157
Tail function score up to day 360, higher is better. Injured controls (dotted) stay low, both BPC-157 doses climb. The top line is surgery without the injury. Figure 2 from Perovic et al., J Orthop Surg Res 2019, CC BY.
Read it on PubMed

06Male rats

Memory recovered after a stroke-like injury

Vukojević et al. · Brain Behav, 2020 · Zagreb · male rats with both neck arteries clamped for 20 minutes, group size not stated in the abstract

Title of the study: The effect of BPC 157 on hippocampal ischemia/reperfusion injuries in rats

BPC-157 was applied to the operated area 30 seconds after the clamping. At 24 and 72 hours it counteracted both early and delayed damage to the hippocampus, and the rats fully recovered on memory, balance and coordination tests. [8]

Counts of surviving neurons in the hippocampus at 24 and 72 hours
Nerve cells in the hippocampus at 24 and 72 hours. B is BPC-157, C is control: fewer damaged cells and more healthy ones with BPC-157. Figure 4 from Vukojević et al., Brain Behav 2020, CC BY.
Read it on PubMed

Heart

07Rats · 10 per group

Protects the heart

Barisic et al. · Biomedicines, 2022 · Zagreb · rats given isoprenaline, a drug that causes a heart attack, 10 per group

Title of the study: BPC 157 may counteract myocardial infarction induced by isoprenaline in rats

BPC-157 lowered every heart damage marker: CK, CK-MB, LDH and troponin T. The treated hearts showed no visible infarcted area, the ECG showed no ischemic changes, and pumping function was kept. [9]

Four rat hearts after isoprenaline: infarcted in the controls, no visible damage with BPC-157
Rat hearts after isoprenaline. (a) saline: infarct. (b) nitric oxide blocker: larger. (c) L-arginine: smaller. (d) BPC-157: none visible. Figure 14 from Barisic et al., Biomedicines 2022, CC BY.
Read it on PubMed

Eyes

08Rats · 6 per group

Eye pressure back to normal in glaucoma

Kralj et al. · Biomedicines, 2021 · Zagreb · rats with glaucoma made by closing 3 eye veins, 6 per group and time point

Title of the study: BPC 157 therapy of rat glaucoma

As eye drops, an injection or in drinking water, before or after the injury, BPC-157 brought eye pressure back to normal right away. The retinal nerve cells and the optic nerve were preserved. [10]

Eye pressure over time in glaucoma rats, control against BPC-157
Eye pressure in mmHg up to day 42. White bars are controls, grey bars BPC-157: eye drops (a, d), by mouth (b, e) or injection (c, f), before or 24 hours after the injury. Figure 1 from Kralj et al., Biomedicines 2021, CC BY.
Read it on PubMed

09Rats · 24 in total

Prevents organ damage

Demirtaş et al. · Medicina, 2025 · Ankara, Turkey · 24 male rats, 6 per group

Title of the study: Protective effects of BPC 157 on liver, kidney and lung distant organ damage

Blood flow to the leg was cut for 45 minutes and then restored for 2 hours, which damages organs far away. With BPC-157 there was less damage in the kidneys, lungs and liver. [11]

Kidney tissue under the microscope: severe damage without BPC-157, mild with it
Kidney tissue: severe damage after the blocked leg, mild with BPC-157. Figure 1 from Demirtaş et al., Medicina 2025, CC BY.
Read it on PubMed

Put them together and one line runs through them. Whenever blood supply was the problem, from a cut tendon to a clamped artery, BPC-157 protected the tissue in rats. What none of them shows is the same thing in living people.

BPC-157 for hair growth

A post on X: a man's hair after 2 years on finasteride without improvement, then 1 mg BPC-157 on the scalp. Two photos show thick, curly hair.
A case I shared on X: 2 years on finasteride with no improvement, then 1 mg of BPC-157 on the scalp. One man's report, not a trial.

A hair follicle is one of the fastest growing tissues in the body, and it lives on blood. Every nutrient it builds hair from, and every hormone that tells it to grow, reaches it through the small vessels wrapped around it.

Blood flow. In mice, each follicle grows its own net of vessels when it enters the growth phase, driven by VEGF, and the vessels shrink back when it rests. Giving follicles more VEGF made hair regrow faster, with bigger follicles and thicker hairs. Blocking VEGF did the opposite: slower growth and smaller follicles [12]. This is the pathway BPC-157 works on. In rats and in human vessel cells it raised VEGFR2, the receptor VEGF acts through, and grew new vessels where blood flow had been lost [1].

Inflammation. Pattern hair loss is not only hormones. Around the shrinking follicles sits a slow, low-grade inflammation: immune cells gathered at the follicle and scar tissue building up in its sheath. Researchers call it microinflammation and see it as one of the steps that miniaturizes the follicle over the years [13]. Across the animal studies, BPC-157 lowered inflammatory cytokines [14].

More vessels to feed the follicle, less inflammation strangling it. That is why I think BPC-157 belongs on the scalp. No study has tested it on hair yet, in animals or in people, so the photo above is a case, not proof.

BPC-157 and the gut

This is where BPC-157 comes from, and where the rat data is most consistent.

  • Stomach lining. In rats it protected the stomach against alcohol, restraint stress and indomethacin, a common painkiller, at 10 micrograms and even 10 nanograms per kg [15].
  • Fistulas. Rats with an open channel between the colon and the skin healed, with the peptide given by mouth or by injection. A corticosteroid given for comparison made healing worse [16].
  • Lost blood supply to the colon. When the vessels to a colon segment were tied off, BPC-157 brought blood flow back quickly. By day 10 the lining was almost completely spared [17].

Notice the pattern again: blood flow. My full take on the gut is in BPC-157 for leaky gut.

Tendons, ligaments and muscle

  • Achilles tendon. After the tendon was cut, treated rats recovered load, walking and structure over 14 days, up to full tendon integrity. It was tested at doses from 10 micrograms down to 10 picograms per kg [18].
  • Knee ligament. Over 90 days it improved healing of a cut ligament in rats. It worked as an injection, as a cream on the injury and in drinking water [19].
  • Muscle on steroids. Corticosteroids slow muscle healing. In crushed rat muscle, BPC-157 gave faster healing and full return of function, and completely reversed the damage the steroid did [20].

The systematic review saw the same thing across 35 animal studies: better function, structure and strength after muscle, tendon, ligament and bone injuries [14]. The doses used in those studies are in BPC-157 dosage, and how it compares with the other healing peptide is in BPC-157 vs TB-500.

Every human study so far

Here is all of it. Three studies, about 30 people.

30 people studied0 placebo groups

Bladder pain Lee 2024 · 12 women · one injection procedure

10 reported complete relief, 2 reported 80%. No adverse events.

Knee pain Lee 2021 · 16 patients · looked back, phone survey

14 of 16 reported improvement. 11 of the 12 who got BPC-157 alone.

IV safety Lee 2025 · 2 adults · 10 mg, then 20 mg

No change in heart, liver, kidney, thyroid or blood sugar markers.

improvedpartly improvedno change measured
Figure 1 Every human study of BPC-157 published so far [21] [2] [22]. None had a placebo group, so none can separate the peptide from the expectation.
  • Bladder pain. 12 women aged 39 to 76 with interstitial cystitis, none helped by pentosan, the standard drug. They got 10 mg of BPC-157 injected around the bladder in one procedure. 10 reported complete relief and 2 reported 80%. No adverse events [21].
  • Knee pain. A clinic looked back at 17 patients and reached 16 of them by phone. 11 of the 12 who got BPC-157 alone reported improvement, 14 of 16 overall. No pain scale or scan was used, only the phone survey [2].
  • IV safety. 2 adults, aged 58 and 68, got 10 mg and then 20 mg by infusion. Their heart, liver, kidney, thyroid and blood sugar markers did not change [22].

The results look great. The designs are weak: no placebo, no blinding, tiny groups, and patients rating themselves. Even the counting changes the answer. The 2025 systematic review reports the same knee study as 7 of 12 patients with relief lasting more than 6 months [14].

How long BPC-157 lasts in the body

Not long. In rats and dogs its half-life was under 30 minutes, and it breaks down into ordinary amino acids [23].

<30 minhalf-life in the blood of rats and dogs
14–19%reaches the blood after a muscle injection in rats
45–51%the same figure in dogs
Amino acidswhat it breaks down into
Figure 2 How the body handles BPC-157, from the one full pharmacokinetics study, in rats and dogs [23]. No such study exists in people.

That creates a puzzle. The molecule is gone within hours, yet in the tendon and ligament studies the benefits built up over 2 to 13 weeks. My read: it starts a repair process, mainly new blood vessels, and the process keeps going after the peptide is gone. That is my hypothesis, not something a study has shown.

How long until it works in people? Nobody has measured it. In rats, the tendon differences showed up within the first two weeks.

Oral capsules vs injections

BPC-157 is unusually stable in gastric juice. That is why oral forms exist at all. Most peptides would simply be digested.

In rats, oral dosing worked in several studies: in drinking water for the ligament [19], the fistula [16] and the kidney study [24]. Injections were used in most of the tendon and muscle work.

No study has compared the two routes in people. Anyone who tells you one route is proven better is guessing. I go through both in oral BPC-157 vs injection.

Other findings in rats

  • Kidneys. Rats got gentamicin, an antibiotic that damages the kidneys, at 100 mg/kg for 8 days. With BPC-157, urea and creatinine stayed close to normal and the kidney tubules were preserved [24].
  • Amphetamine. One dose of BPC-157 at the start reduced the stereotyped behavior amphetamine causes in rats, and the effect held through challenges up to day 46 [25]. More in BPC-157, dopamine and Adderall.

Is BPC-157 safe?

No study has shown harm, in animals or in the 30 people studied. That is not the same as proven safe. The 2025 systematic review found no clinical safety data at all [14].

The bigger risks are practical. BPC-157 is not FDA approved and is sold through unregulated channels. A 2026 review of injectable peptides lists the problems [26]:

01ContaminationUnregulated labs, no required testing.
02ImpuritiesBy-products of a poorly controlled synthesis.
03Wrong doseWhat the label says and what is inside can differ.
04Unwanted vessel growthTheoretical, but it follows from the mechanism.
Figure 3 The risks a 2026 review lists for unregulated peptides like BPC-157 [26]. Three of the four are about the product, not the molecule.

Because it grows blood vessels, anyone with cancer or a history of it should talk to their doctor first. That risk is theoretical, but it follows straight from the mechanism. The same goes if you are pregnant or take prescription drugs. If you compete in tested sport, check your organization's rules before you touch any research peptide.

30 years of BPC-157 research

  1. 1996Stomach protection in rats against alcohol, stress and a painkiller [15]
  2. 2002Calms amphetamine-driven behavior in rats, up to day 46 [25]
  3. 2003Cut Achilles tendons heal in rats within 14 days [18]
  4. 2008Colon-to-skin fistulas heal in rats, by mouth or injection [16]
  5. 2010Knee ligament and steroid-damaged muscle heal in rats [19]
  6. 2017The VEGFR2 mechanism, in rats and human vessel cells [1]
  7. 2019Review: every study positive, most in rodents, few labs [27]
  8. 2021First human report: knee pain, 16 patients [2]
  9. 2022Half-life under 30 minutes, in rats and dogs [23]
  10. 2024Bladder pain, 12 women [21]
  11. 2025IV safety test in 2 adults. Systematic review: 35 animal studies, 1 human [22]
  12. 2026Kidney protection in rats. Sports medicine reviews: human claims still unproven [24]
Figure 4 Thirty years of research, with the human studies marked. Almost all of the story was written in rats.

The newest reviews agree on the next step. Not more rat studies. A proper human trial with a placebo group.

Frequently asked questions

What are the benefits of BPC-157?

In rats: faster healing of tendons, muscle, ligaments and the gut lining, new blood vessels in tissue that lost its blood supply, and protection of the heart, brain, spinal cord, eyes and kidneys in injury models. In people, three small studies without a placebo group reported less knee and bladder pain. None of these benefits is proven in humans.

What is BPC-157?

A lab-made peptide of 15 amino acids, copied from a protein found in human gastric juice. BPC stands for body protection compound. It is studied for healing of the gut lining, tendons, ligaments and muscle, almost entirely in rats.

Does BPC-157 work in humans?

Nobody knows yet. There are three small human studies, about 30 people in total: bladder pain, knee pain and an IV safety test. The results were positive, but none had a placebo group.

How does BPC-157 work?

Its best mapped action is on blood vessels. In rats and human vessel cells it raised VEGFR2 receptors and switched on the Akt-eNOS signal that grows new capillaries, which brings blood flow back to injured tissue.

How long does BPC-157 take to work?

No study has timed it in people. In rats, differences in tendon healing showed up within the first two weeks, and the ligament study ran for 90 days.

What is the half-life of BPC-157?

Under 30 minutes in rats and dogs. It breaks down into ordinary amino acids. No pharmacokinetic study has been done in people.

Is BPC-157 safe?

No harm was reported in animal studies or in the three human pilots, but there is no formal clinical safety data. The main practical risks are contamination, impurities and wrong doses in unregulated products.

Is BPC-157 legal?

It is not FDA approved as a drug and is usually sold for research use. A 2025 review notes it is banned in professional sports, so tested athletes should check their organization's rules.

Does BPC-157 work for hair loss?

There is no published study of BPC-157 on hair, in animals or in people. The idea rests on two things it does in animal studies, more blood vessels through VEGF and less inflammation, both of which the follicle depends on, and on shared cases, which are not trials.

Sources

  1. Hsieh MJ, Liu HT, Wang CN et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl) 2017. PMID 27847966
  2. Lee E, Padgett B Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Altern Ther Health Med 2021. PMID 34324435
  3. Yildirim AK, Dastan AO, Demeli Ertus M et al. Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery. J Clin Med 2026. PMID 42123221
  4. Japjec M, Horvat Pavlov K, Petrovic A et al. Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats. Biomedicines 2021. PMID 34829776
  5. Matek D, Matek I, Staresinic E et al. Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats. Pharmaceutics 2025. PMID 39861766
  6. Skorjanec S, Dolovski Z, Kocman I et al. Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. Dig Dis Sci 2009. PMID 18649140
  7. Perovic D, Kolenc D, Bilic V et al. Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats. J Orthop Surg Res 2019. PMID 31266512
  8. Vukojević J, Vrdoljak B, Malekinušić D et al. The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats. Brain Behav 2020. PMID 32558293
  9. Barisic I, Balenovic D, Udovicic M et al. Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats. Biomedicines 2022. PMID 35203478
  10. Kralj T, Kokot A, Zlatar M et al. Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma. Biomedicines 2021. PMID 35052769
  11. Demirtaş H, Özer A, Yıldırım AK et al. Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia-Reperfusion Injury. Medicina (Kaunas) 2025. PMID 40005408
  12. Yano K, Brown LF, Detmar M Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001. PMID 11181640
  13. Mahé YF, Michelet JF, Billoni N et al. Androgenetic alopecia and microinflammation. Int J Dermatol 2000. PMID 10971723
  14. Vasireddi N, Hahamyan H, Salata MJ et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J 2025. PMID 40756949
  15. Sikirić P, Seiwerth S, Grabarević Z et al. Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity. Dig Dis Sci 1996. PMID 8769287
  16. Klicek R, Sever M, Radic B et al. Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. J Pharmacol Sci 2008. PMID 18818478
  17. Duzel A, Vlainic J, Antunovic M et al. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J Gastroenterol 2017. PMID 29358856
  18. Staresinic M, Sebecic B, Patrlj L et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res 2003. PMID 14554208
  19. Cerovecki T, Bojanic I, Brcic L et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res 2010. PMID 20225319
  20. Pevec D, Novinscak T, Brcic L et al. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit 2010. PMID 20190676
  21. Lee E, Walker C, Ayadi B Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Altern Ther Health Med 2024. PMID 39325560
  22. Lee E, Burgess K Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med 2025. PMID 40131143
  23. He L, Feng D, Guo H et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol 2022. PMID 36588717
  24. Vukoja I, Vlainic J, Francina M et al. Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats. J Physiol Pharmacol 2026. PMID 42533460
  25. Sikiric P, Jelovac N, Jelovac-Gjeldum A et al. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. Acta Pharmacol Sin 2002. PMID 11978191
  26. Moiz A, O'Keefe EL, O'Keefe JH Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs. Mo Med 2026. PMID 42757290
  27. Gwyer D, Wragg NM, Wilson SL Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res 2019. PMID 30915550

This guide is educational and is not medical advice. Talk to a qualified clinician before starting any compound, especially if you take medication, are pregnant, or compete in tested sport.

The BPC-157 I use

500 mcg × 100 capsules, 99% purity, third-party COA for every batch. Sold for research use.

Buy BPC-157